In 2024, ASCO published a guideline for clinicians, patients, and policymakers in resource-constrained settings on the treatment of patients with metastatic breast cancer (MBC). 1 The purpose of that ...
—Building off of earlier findings, researchers sought to determine rates of neoadjuvant systemic therapy (NST) among U.S. women with cT1–2 N0 M0 HER2-positive breast cancer and identify factors ...
Dr. Banu Arun and Dr. Sana Al Sukhun share recommendations from the newest ASCO resource-stratified guideline on systemic treatment for patients with metastatic breast cancer. They describe the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results